highperformr logo

ALK's Overview

Total employees2787
HeadquartersHørsholm
Founded1923

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the diagnosis and treatment of allergies. With over a century of experience, ALK is a world leader in allergy immunotherapy (AIT), a unique treatment that not only reduces allergic symptoms but also addresses the underlying cause of the allergy. The company offers a comprehensive portfolio of AIT products, including sublingual immunotherapy tablets (SLIT-tablets) and subcutaneous immunotherapy (SCIT). ALK is committed to innovation, continuously investing in R&D to develop new and improved allergy treatments and diagnostic tools, aiming to improve the quality of life for millions of people suffering from allergies worldwide.

Where is ALK's Headquarters?

HQ Function

The Hørsholm headquarters serves as the central hub for ALK's global operations, including corporate management, strategic planning, research and development leadership, global marketing, and administrative functions.

Notable Features:

The headquarters is part of a modern campus in the DTU Science Park, fostering collaboration and innovation, and includes advanced research laboratories and office spaces reflecting the company's scientific focus.

Work Culture:

The work culture emphasizes scientific excellence, innovation, patient-centricity, and collaboration, typical of a research-driven pharmaceutical company. It also reflects Danish workplace values of trust, work-life balance, and employee well-being.

HQ Significance:

The Hørsholm HQ is the nerve center for ALK's global strategy and R&D in allergy immunotherapy, driving its mission. Its location in Denmark positions it within a strong life sciences cluster.

Values Reflected in HQ: The headquarters' design and operations likely reflect ALK's core values: scientific rigor, innovation, quality, integrity, and a focus on patient well-being, with an environment supporting teamwork and continuous improvement.

Location:

ALK supports its global operations through a network of research and development facilities, state-of-the-art manufacturing sites in Denmark, France, Spain and the USA, and sales and marketing offices across Europe, North America, and key international markets including China. This global infrastructure enables ALK to develop, produce, and distribute its allergy immunotherapy treatments and diagnostics to patients in over 40 countries worldwide. Key functions supported globally include R&D, clinical trials, manufacturing, quality assurance, regulatory affairs, sales, marketing, and medical affairs.

Street Address:

Bøge Alle 1

City:

Hørsholm

State/Province:

Hovedstaden

Country:

Denmark

ALK's Global Presence

Round Rock, Texas, USA

Address: 1700 Royston Lane, Round Rock, TX 78664, USA

Supports the commercialization, distribution, and market access of allergy immunotherapy products for patients in the United States and North America.

Vandeuil, France

Address: Site de Vandeuil, 161 rue des Montepillois, 51140 Vandeuil, France

Focuses on the large-scale production and quality control of allergy treatments, ensuring consistent supply for European healthcare providers and patients.

Madrid, Spain

Address: Miguel Fleta, 19, 28037 Madrid, Spain

Manages sales, marketing, distribution, medical affairs, and regulatory activities for ALK's products in Spain, a key European market for the company.

Buying Intent Signals for ALK

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of ALK

As of April 2025, ALK' leadership includes:

Peter Halling - President & CEO
Claus Stevelt - Executive Vice President, CFO
Henrik Jacobi - Executive Vice President, Research and Development
Søren Niegel - Executive Vice President, Commercial Operations Europe
Gordana Ristic - Executive Vice President, Commercial Operations International & North America
Lisbeth Juhl Christensen - Executive Vice President, People & Organisation
Christian G. Meyer - Executive Vice President, Product Supply

Investors of ALK

ALK has been backed by several prominent investors over the years, including:

The Lundbeck Foundation (Lundbeckfonden)
Various institutional investors (e.g., pension funds, investment management firms)

Executive New Hires/Exits in the Last 12 Months

Hire3
Exits1

ALK-Abelló has made key appointments to its executive team in the past 12 months, notably strengthening its finance, commercial, and product supply leadership. This includes the permanent appointment of its CFO and new EVPs for Commercial Operations Europe and Product Supply, alongside one departure.

Departures

Søren Sprøgel, Søren Sprøgel departed from his role as EVP, Product Supply.

New Appointments:

Christian G. Meyer, Christian G. Meyer appointed as new EVP, Product Supply.
Søren Niegel, Søren Niegel joined ALK as EVP, Commercial Operations Europe.
Claus Stevelt, Claus Stevelt was permanently appointed as Executive Vice President & CFO.

Technology (Tech Stack) used by ALK

Discover the tools ALK uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

ALK Email Formats and Examples

ALK-Abelló likely utilizes standardized email formats for its employees. Common corporate patterns involve combinations of an employee's first name, last name, or initials. Specific departmental or regional variations might exist.

Commonly attempted formats include [first_initial][last_name]@alk.net (e.g., jdoe@alk.net) or [first_name].[last_name]@alk.net (e.g., jane.doe@alk.net). Some specific internal contacts might use an initials-based system (e.g., xxYY@alk.net).

Format

jdoe@alk.net or jane.doe@alk.net

Example

65%

Success rate

News and media

GlobeNewswireMay 7, 2024

ALK-Abelló News: ALK delivers 13% revenue growth and a 26% EBIT margin in Q1, maintains full-year outlook

ALK reported strong Q1 2024 financial results with 13% revenue growth (14% in local currencies), driven by broad-based growth, especially in tablet sales which grew by 22%. The EBIT margin reached 26%. The company maintained its full-year financial outlook for 2024....more

GlobeNewswireApril 10, 2024

ALK-Abelló News: ALK’s tablet franchise continues to gain market share in Europe

ALK announced that its allergy immunotherapy tablet (AIT) franchise gained further market share in its European key markets during the first quarter of 2024. This growth highlights the increasing adoption of ALK's tablet-based treatments for respiratory allergies....more

GlobeNewswireFebruary 7, 2024

ALK-Abelló News: ALK delivers on 2023 outlook and provides guidance for continued growth and improved earnings in 2024

ALK reported its full-year 2023 results, meeting its financial outlook with revenue growth of 11% in local currencies. The company also provided an outlook for 2024, anticipating continued revenue growth and significantly improved earnings....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including ALK, are just a search away.